PITTSBURGH & SAN FRANCISCO–(BUSINESS WIRE)–Today, Tim Hwang is joining Abridge, the leader in generative AI for clinical documentation, as General Counsel. Hwang, a nationally renowned expert on technology and AI policy, will spearhead legal strategy, public policy, and trust and safety initiatives.
Hwang’s experience at the intersection of AI and public policy is extensive, having held leading positions most recently at Inflection AI, Substack, and Google, where he was the company’s global public policy lead on AI, leading outreach to government and civil society on issues surrounding the social impact of the technology. He has collaborated with the White House on voluntary commitments around AI safety and responsible deployment and has also served as a research fellow at Georgetown’s Center for Security and Emerging Technology. He was also the director of the Harvard-MIT Ethics and Governance AI initiative.
“Generative AI has the potential to significantly reshape healthcare for the better,” said Hwang. “Abridge is at the forefront of that change, establishing the norms around the thoughtful and patient-first deployment of this type of technology for decades to come.”
Hwang joins Abridge at a time of rapid expansion for Abridge, including successful deployments at the University of Vermont Health Network, CHRISTUS Health, UChicago Medicine, Sutter Health, Yale New Haven Health System, UCI Health, Emory Healthcare, The University of Kansas Health System, UPMC, and dozens of other health systems. Recently, Mayo Clinic, Epic and Abridge have also partnered on a generative AI ambient documentation workflow for nurses. Earlier this year, Abridge announced a $150M Series C financing, which includes a strategic investment from NVIDIA.
“Tim Hwang is a visionary who will help Abridge continue to deliver on the future of clinical documentation in healthcare,” said Dr. Shiv Rao, CEO and Founder of Abridge. “We are thrilled that Tim has joined our team at a time when the AI policy debate is developing in Washington. Abridge will be a leader in ensuring that generative AI is deployed thoughtfully and responsibly to transform the way clinicians work.”
In addition to his deep well of experience with AI policy, Hwang is a thought leader and published author in related arenas. Hwang wrote Subprime Attention Crisis, a book about the structural vulnerabilities in the market for online advertising. He’s also published extensively on the policy issues surrounding emerging technologies, including in Wired and The Atlantic. He has been a guest on the Ezra Klein podcast, as well as on dozens of other respected programs. Forbes Magazine has called him The Busiest Man on the Internet.
About Abridge
Abridge was founded in 2018 with the mission of powering deeper understanding in healthcare. The AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients. With support for 14+ languages and 50+ specialties, Abridge is able to support a wide range of clinician and patient encounters.
Abridge’s enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time with deep EMR integrations. Powered by Linked Evidence and their auditable AI, Abridge is the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, Abridge is setting the industry standards for the responsible deployment of AI across health systems.
In a survey by KLAS across multiple systems that have adopted the platform, Abridge scored a 95.3 rating (out of 100) with a grade of A+ on the likelihood to recommend and time to outcomes being reported as immediate. Abridge was also recently recognized on the 2024 Forbes AI 50 list, alongside companies like OpenAI, Anthropic, Databricks, and others.
